FREEOX BIOTECH
Based on the knowledge of oxidative stress and uric acid, Freeox Biotech is developing neuroprotective therapies to reduce the damage resulting from ischemia and in this way improve the recovery of the patients. Ox-01 is Uric Acid used as a medicinal product. Ox-01 has a proven effect in preventing the damage caused by reperfusion after stroke. Ox-02 Uricoline is a molecule resulting from the association of Ox-01 and Citicoline. Citicoline is an intermediate in the generation of phosphatidylcholine from choline.
FREEOX BIOTECH
Industry:
Biotechnology Health Care Neuroscience
Founded:
2017-03-01
Address:
Barcelona, Catalonia, Spain
Country:
Spain
Website Url:
http://www.freeoxbiotech.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
500 K EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API WordPress Font Awesome Wordpress Plugins Mobile Non Scaleable Content Euro PHP
Similar Organizations
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Impact Biomedicines
Impact Biomedicines is pioneering the development of life-changing treatments for patients.
Current Advisors List
Current Employees Featured
Founder
Investors List
Montserrat Esteve
Montserrat Esteve investment in Seed Round - FreeOx Biotech
Javier Alsina
Javier Alsina investment in Seed Round - FreeOx Biotech
Official Site Inspections
http://www.freeoxbiotech.com
Unable to get host informations!!!
